LUDAOPEI HOSPITAL

Arsenic Sulfide in Acute Promyelocytic Leukemia (APL) 5-year D

5-year DFSDFS:disease-free survival of Arsenic Sulfide in acute promyelocytic leukemia (APL) is about 95%. This arsenic sulfide medicine is the patent of our hospital.

History +
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
Medical Data -
Environment +
- Beijing Lu Daopei Hospital
- Hebei Yanda Lu Daopei Hospital
News +
- Events & News
- Patient Story

Research & Education
Patient Education

Stay in Touch

©2017 Lu Daopei hospital-22 Tongji South Rd, Yizhuang Ecomonic and Technological Development Zone, Daxing District, Beijing, China. All rights reserved.

京公网安备13108202000843号冀ICP备18002416号-1